APA (7th ed.) Citation

Ferrarotto, R., Bobbili, P., Bowles, D., Even, C., Gordon, G., Gutierrez, A., . . . Ho, A. (2023). 903P AL101 therapy in patients with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC): Final ACCURACY trial results and meta-analysis of clinical outcomes. Annals of Oncology, 34, S575. https://doi.org/10.1016/j.annonc.2023.09.2048

Chicago Style (17th ed.) Citation

Ferrarotto, R., et al. "903P AL101 Therapy in Patients with Recurrent/metastatic (R/M) Adenoid Cystic Carcinoma (ACC): Final ACCURACY Trial Results and Meta-analysis of Clinical Outcomes." Annals of Oncology 34 (2023): S575. https://doi.org/10.1016/j.annonc.2023.09.2048.

MLA (9th ed.) Citation

Ferrarotto, R., et al. "903P AL101 Therapy in Patients with Recurrent/metastatic (R/M) Adenoid Cystic Carcinoma (ACC): Final ACCURACY Trial Results and Meta-analysis of Clinical Outcomes." Annals of Oncology, vol. 34, 2023, p. S575, https://doi.org/10.1016/j.annonc.2023.09.2048.